SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-280241
Filing Date
2022-11-08
Accepted
2022-11-08 16:51:45
Documents
35
Period of Report
2022-11-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d388226d8k.htm   iXBRL 8-K 148141
2 EX-2.1 d388226dex21.htm EX-2.1 598054
3 EX-3.1 d388226dex31.htm EX-3.1 4424
4 EX-3.2 d388226dex32.htm EX-3.2 11505
5 EX-4.1 d388226dex41.htm EX-4.1 65970
6 EX-10.1 d388226dex101.htm EX-10.1 234244
7 EX-10.2 d388226dex102.htm EX-10.2 238398
8 EX-10.3 d388226dex103.htm EX-10.3 376722
9 EX-10.4 d388226dex104.htm EX-10.4 530722
10 EX-10.5 d388226dex105.htm EX-10.5 263658
11 EX-10.6 d388226dex106.htm EX-10.6 41801
12 EX-10.7 d388226dex107.htm EX-10.7 52536
13 EX-10.8 d388226dex108.htm EX-10.8 51511
14 EX-10.9 d388226dex109.htm EX-10.9 51624
15 EX-10.10 d388226dex1010.htm EX-10.10 44008
16 EX-10.11 d388226dex1011.htm EX-10.11 38882
17 EX-10.12 d388226dex1012.htm EX-10.12 23726
18 EX-10.13 d388226dex1013.htm EX-10.13 32144
19 EX-99.1 d388226dex991.htm EX-99.1 20914
23 GRAPHIC g388226g1104074135383.jpg GRAPHIC 4364
24 GRAPHIC g388226g1104074135711.jpg GRAPHIC 3064
25 GRAPHIC g388226g1104074135804.jpg GRAPHIC 2533
26 GRAPHIC g388226g1105104244334.jpg GRAPHIC 2771
27 GRAPHIC g388226g1105104244428.jpg GRAPHIC 4070
  Complete submission text file 0001193125-22-280241.txt   3617648

Data Files

Seq Description Document Type Size
20 XBRL TAXONOMY EXTENSION SCHEMA spry-20221104.xsd EX-101.SCH 2884
21 XBRL TAXONOMY EXTENSION LABEL LINKBASE spry-20221104_lab.xml EX-101.LAB 19483
22 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE spry-20221104_pre.xml EX-101.PRE 12172
29 EXTRACTED XBRL INSTANCE DOCUMENT d388226d8k_htm.xml XML 3734
Mailing Address 500 FAIRVIEW AVENUE NORTH, SUITE 600 SEATTLE WA 98109
Business Address 500 FAIRVIEW AVENUE NORTH, SUITE 600 SEATTLE WA 98109 206-456-2900
Silverback Therapeutics, Inc. (Filer) CIK: 0001671858 (see all company filings)

IRS No.: 811489190 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39756 | Film No.: 221369657
SIC: 2834 Pharmaceutical Preparations